Medicare Enrolled
Dr. Solomon Forouzesh, M.D.
Rheumatology · Culver City, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Forouzesh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Forouzesh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Forouzesh
Dr. Solomon Forouzesh is a rheumatology specialist in Culver City, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Forouzesh performed 8,125 Medicare services across 2,962 unique beneficiaries.
Between the years covered by Open Payments, Dr. Forouzesh received a total of $129,806 from 57 pharmaceutical and/or device companies across 1334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Forouzesh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 24% volume in CA
$129,806 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,125
Medicare services
Top 24% in CA for rheumatology
2,962
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~451 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,084 | $75 | $200 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
977 | $27 | $50 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
922 | $12 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
475 | $8 | $15 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
279 | $0 | $5 |
| Injection, methylprednisolone acetate, 40 mg | 212 | $6 | $50 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
196 | $1 | $15 |
| Venipuncture for blood draw Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older. |
181 | $15 | $50 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
178 | $21 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
157 | $105 | $250 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
138 | $100 | $250 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
137 | $46 | $250 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
112 | $99 | $300 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
101 | $105 | $350 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
98 | $172 | $400 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
90 | $28 | $50 |
| X-ray of entire middle and lower spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the entire middle and lower spine to visualize the bones and structures in these areas. |
86 | $63 | $350 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
86 | $44 | $300 |
| Annual alcohol misuse screening, 5 to 15 minutes | 75 | $21 | $50 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
74 | $13 | $50 |
| Methotrexate sodium, 50 mg | 73 | $2 | $50 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
55 | $221 | $600 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
53 | $63 | $184 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
52 | $162 | $400 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
45 | $171 | $400 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
45 | $84 | $300 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
42 | $55 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $138 | $350 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $154 | $450 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
16 | $172 | $600 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
13 | $178 | $392 |
| New patient office visit, complex (60-74 min) | 12 | $188 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
28.9% medium
70.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$129,806
Total received (2018-2024)
Avg $18,544/year across 7 years
Top 8% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,334
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$93,456 (72.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,004 (19.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$11,346 (8.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,135
2023
$6,204
2022
$11,144
2021
$7,195
2020
$8,196
2019
$49,506
2018
$40,426
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Scientific Affairs, LLC
$1,230
Amgen Inc.
$1,211
ABBVIE INC.
$1,109
Janssen Biotech, Inc.
$569
GlaxoSmithKline, LLC.
$416
AstraZeneca Pharmaceuticals LP
$395
Novartis Pharmaceuticals Corporation
$356
Mallinckrodt Hospital Products Inc.
$298
Lilly USA, LLC
$293
Boehringer Ingelheim Pharmaceuticals, Inc.
$202
PFIZER INC.
$189
UCB, Inc.
$151
Fresenius Kabi USA, LLC
$125
Exact Sciences Corporation
$117
Octapharma USA, Inc.
$96
Alexion Pharmaceuticals, Inc.
$76
SCILEX PHARMACEUTICALS INC.
$69
Alvogen Inc
$47
Novo Nordisk Inc
$36
Aurinia Pharma U.S., Inc.
$27
Kiniksa Pharmaceuticals International, plc
$25
Madrigal Pharmaceuticals
$24
Merck Sharp & Dohme LLC
$20
Genentech USA, Inc.
$20
Radius Health, Inc.
$16
SHIELD THERAPEUTICS INC
$14
Top 3 companies account for 49.8% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$53,602
Amgen Inc.
$29,201
AbbVie, Inc.
$21,787
ABBVIE INC.
$3,203
AbbVie Inc.
$2,398
Janssen Scientific Affairs, LLC
$2,148
Lilly USA, LLC
$1,952
Janssen Biotech, Inc.
$1,692
GlaxoSmithKline, LLC.
$1,576
PFIZER INC.
$1,555
Novartis Pharmaceuticals Corporation
$1,472
AstraZeneca Pharmaceuticals LP
$1,471
UCB, Inc.
$1,241
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,109
Radius Health, Inc.
$876
Mallinckrodt Hospital Products Inc.
$676
Horizon Therapeutics plc
$528
Novo Nordisk Inc
$499
GENZYME CORPORATION
$479
E.R. Squibb & Sons, L.L.C.
$234
Gilead Sciences, Inc.
$218
Fresenius Kabi USA, LLC
$175
SANOFI-AVENTIS U.S. LLC
$154
Exact Sciences Corporation
$153
Allergan, Inc.
$129
Alexion Pharmaceuticals, Inc.
$121
Mallinckrodt Enterprises LLC
$116
Genentech, Inc.
$116
Octapharma USA, Inc.
$96
Shield Therapeutics Inc
$89
SCILEX PHARMACEUTICALS INC.
$69
Genentech USA, Inc.
$61
Aurinia Pharma U.S., Inc.
$51
Alvogen Inc
$47
Merck Sharp & Dohme Corporation
$40
Antares Pharma, Inc.
$35
Sandoz Inc.
$29
Biohaven Pharmaceutical Holding Company Ltd.
$29
Kiniksa Pharmaceuticals, Ltd.
$28
SOBI, INC
$27
Lundbeck LLC
$25
Kiniksa Pharmaceuticals International, plc
$25
Fidia Pharma USA Inc.
$24
Madrigal Pharmaceuticals
$24
Kowa Pharmaceuticals America, Inc.
$24
Sobi, Inc
$22
Eisai Inc.
$20
Merck Sharp & Dohme LLC
$20
IMPEL PHARMACEUTICALS INC.
$19
Organon LLC
$19
Scilex Pharmaceuticals Inc.
$16
Zyla Life Sciences, Inc.
$16
Egalet US Inc
$16
Acerta Pharma LLC
$14
SHIELD THERAPEUTICS INC
$14
MEDEXUS PHARMA, INC.
$12
Horizon Pharma plc
$11
Top 3 companies account for 80.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AIRSUPRA · AMJEVITA · Actemra · Aimovig · Arcalyst · BELSOMRA · BENLYSTA · BRINTELLIX · Bimzelx · CABENUVA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · CREON · CYLTEZO · Cimzia · Cologuard Collection Kit · DUEXIS · DUPIXENT · Dayvigo · ELIQUIS · ELREXFIO · EVENITY · EVUSHELD · Enbrel · FARXIGA · GARDASIL · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · IDACIO · KEVZARA · KRYSTEXXA · Kineret · LINZESS · LUPKYNIS · LYRICA · Livalo · MOUNJARO · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · Otrexup · Ozempic · PENNSAID · Prolia · QULIPTA · RAYOS · REMICADE · RESMETIROM · RINVOQ · Rasuvo · Repatha · Rinvoq · Rybelsus · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPEVIGO · SPRIX · STELARA · STRENSIQ · Saxenda · TALTZ · TEPEZZA · TERIPARATIDE · TEZSPIRE · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TREMFYA · TRULICITY · Tremfya · Trudhesa · Tyenne · Tymlos · UBRELVY · WAINUA · Wegovy · XELJANZ · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for rheumatology in CA.
Geographic Context
Rheumatologists within 10 mi
203
Per 100K population
2.1
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - WEST LA
0.9 mi
0.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Forouzesh is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with speaking/promotional industry engagement in the top 8% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Forouzesh experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Forouzesh performed 3,084 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Forouzesh receive payments from pharmaceutical companies?
Yes. Dr. Forouzesh received a total of $129,806 from 57 companies across 1,334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Forouzesh's costs compare to other rheumatologists in Culver City?
Dr. Forouzesh's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Forouzesh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Culver City
Browse rheumatologists in Culver City ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in CA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in CA
Which CA rheumatologists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology